Facebook, Inc. (NASDAQ:FB): Goldman said comScore reported that Facebook, Inc.’s domestic mobile unique visitors, from both browsers and apps, were up 4% month to month, their average daily visitors were up 6%, and average minutes per visitor was up 3%. The firm views the shift towards mobile as a positive one, but expects shares to remain volatile given the next lockup that will soon be ending. Shares are Buy rated with a $37 price target.
Whole Foods Market, Inc. (NASDAQ:WFM): Citing their under penetration in markets, brand awareness, and higher margins, Cowen believes that Whole foods Market, Inc. will continue to exceed earnings growth expectations. Shares are Outperform rated.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Following positive preliminary Phase 2 results with PEG-PAL in Phenylketonuria (PKU), Brean Murray raised their price target on BioMarin Pharmaceuticals Inc. The firm said the results were a positive surprise and with its addition to their model, it caused them to raise their price target. Shares are Buy rated.
Philip Morris International, Inc. (NYSE:PM): Wells Fargo said that their analysis found that cigarettes in emerging markets over the past ten years are increasingly affordable. A pack of cigarettes on average costs $1.12 as compared to a Big Mac which runs about $2.89. The firm sees increasing cigarette affordability as a key volume driver for Philip Morris and keeps an Outperform rating on the stock.
Akamai Technologies Inc. (NASDAQ:AKAM): Wells Fargo said that their channel checks in the content delivery network space yielded positive takeaways for Akamai Technologies Inc. The firm believes demand remains strong while pricing remains rational. Wells thinks Akami could top consensus growth expectations in 2013 and keeps an Outperform rating on their stock.